DSS withdraws registration statement citing market conditions

DSS, Inc. (NYSE American: DSS) withdrew its previously filed Registration Statement on Form S-1 with the Securities and Exchange Commission, the company announced.

The company said management and the Board of Directors concluded that proceeding with the offering would not reflect the value DSS believes it is building for shareholders after reviewing current market conditions and deal terms.

"We are focused on executing our business plan and creating long-term value for our shareholders," said Jason Grady, Chief Executive Officer of DSS. "Accessing capital on the right terms, at the right time, is an important part of that discipline."

DSS stated the withdrawal does not reflect any change in the company's business outlook, operating strategy, or confidence in the value of its assets and subsidiaries. The company said it remains positioned to access capital markets and will continue evaluating financing alternatives and opportunities.

Grady noted the company remains focused on advancing strategic initiatives, including a previously announced merger involving Impact Biomedical. DSS operates across multiple business lines including product packaging, biotechnology, commercial lending, and securities and investment management.

The company said it continues to evaluate opportunities to unlock value across its portfolio while maintaining financial and strategic flexibility.

You May Also Be Interested In

• Chilean Cobalt completes Phase 1 at NeoRe rare earth project in Chile
• Galaxy Gaming names Anand Singh as chief technology officer
• Jet.AI signs merger LOI valued at $320M, plans data center spin-off